Qingyuan Zhang

Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial

Sara A. Hurvitz, Fabrice André, Zefei Jiang et al. · The Lancet Oncology · 2015 · 300 citations

Breast Oncology, Oncology, Pharmacology +7

Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial

Zefei Jiang, Wei Li, Xichun Hu et al. · The Lancet Oncology · 2019 · 261 citations

Breast Oncology, Medicine, Pharmacology +8

Tumor‐associated macrophages secrete CC‐chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer

Dongbo Li, Hongfei Ji, Xingjian Niu et al. · Cancer Science · 2019 · 226 citations · Full text

Molecular Subtyping of Triple-Negative Breast Cancers by Immunohistochemistry: Molecular Basis and Clinical Relevance

Shen Zhao, Ding Ma, Yi Xiao et al. · The Oncologist · 2020 · 199 citations · Full text

Inavolisib-Based Therapy in <i>PIK3CA</i> -Mutated Advanced Breast Cancer

Nicholas C. Turner, Seock‐Ah Im, Cristina Saura et al. · New England Journal of Medicine · 2024 · 178 citations